FDA OKs Prasterone for Dyspareunia in Postmenopausal Women FDA OKs Prasterone for Dyspareunia in Postmenopausal Women

The once-daily vaginal insert is indicated to treat women with moderate to severe pain during sexual intercourse.FDA Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Alert Source Type: news